Loading data
RXSTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 134.48 m USD | 139.93 m USD | 89.08 m USD | 49.01 m USD | 22.59 m USD |
| Cost of revenue | 31.47 m USD | 40.98 m USD | 35.31 m USD | 27.68 m USD | 18.08 m USD |
| Gross profit | 103.01 m USD | 98.94 m USD | 53.77 m USD | 21.33 m USD | 4.52 m USD |
| Research and development expense | 38.55 m USD | 34.37 m USD | 29.05 m USD | 25.98 m USD | 24.5 m USD |
| Selling, general and administrative expense | 112.65 m USD | 101.43 m USD | 74.8 m USD | 58.67 m USD | 32.81 m USD |
| Operating profit | -48.19 m USD | -36.9 m USD | -50.09 m USD | -63.32 m USD | -52.79 m USD |
| Interest expense | 19 k USD | 21 k USD | 3.31 m USD | 4.95 m USD | 3.68 m USD |
| Profit before tax | -38.88 m USD | -27.41 m USD | -48.59 m USD | -66.75 m USD | -48.68 m USD |
| Income tax expense | 66 k USD | 50 k USD | 20 k USD | 9 k USD | 8 k USD |
| Net income (reported basis) | -38.9 USD | -27.5 USD | -48.6 USD | -66.8 USD | -48.69 m USD |
| Basic earnings per share | -0.95 USD/share | -0.71 USD/share | -1.41 USD/share | -2.41 USD/share | -3.57 USD/share |
| Diluted earnings per share | -0.95 USD/share | -0.71 USD/share | -1.41 USD/share | -2.41 USD/share | -3.57 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.